In a large U.S. retrospective cohort study published in JAMA Network Open, investigators report that glucagon-like peptide-1 ...

Treatment with incretin-based weight-loss medications, like GLP-1 receptor agonists, after bariatric surgery was associated with significantly lower risks of alcohol use disorder (AUD) and initiation ...

Researchers are studying whether these widely used weight-loss drugs may also be future treatments for alcohol abuse.

GLP-1 medications like semaglutide in Ozempic and Wegovy help people lose weight. But they need to be taken for years, ...